A series of O-benzyl-N-(9-acridinyl)hydroxylamines was prepared, isolated, and evaluated for biological activity using both thermal denaturation and MTT assays. Changes in the thermal denaturation temperature of genomic calf-thymus DNA ranged from +6.6 °C to +20.2 °C. MTT assays on SNB-19 glioblastoma cells provided biological activity that ranged from 17.4 µM to 33.2 µM. Both evaluation methods of biological activity indicate that substitution of the benzyl group by either electron-withdrawing or electron-donating groups provides a measureable benefit in these assays. The two assays agreed on the magnitude of the interaction for each substitution pattern.
Introduction
Aminoacridines have been known for some time as DNA intercalators. Lerman 1 proposed an intercalating model for this class of compounds that has been used to describe the initial interactions resulting in biological activity. In this model, the acridine subunit intercalates between adjacent nucleotide base pairs in duplex DNA and results in the lengthening, stiffening, and unwinding of the complex. The substituents on the acridine nucleus are located outside of the intercalation pocket, allowing for potential interactions with other compounds. The biological activity of this class of compound was further elucidated to involve a ternary complex with Topoisomerase II. 2 9-Aminoacridines, such as the 9-pyridinylaminoacridines, 3 9-aminomethylacridines, 4 acridones, 5 9thioacridines, 6 and 9-anilinoacridines 8 have been studied for their ability to intercalate DNA. These, and other, studies have verified that the proposed model of binding is valid; a strong intercalation of the acridine with duplex DNA requires that the intercalator exist as a cation under physiological conditionsm 7 be planar and aromatic, and possess substitution that is directed away from the site of intercalation.
In our continued exploration of the effect of substitution on the acridine nucleus and the ability of the resulting compounds to interact with duplex and/or quadruplex DNA, we sought to prepare a series of O-benzyl-N-acridinylhydroxylamines to study the effect of the hydroxylamine on the biological activity of this class of compound. 9 Our interest in the hydroxylamine as a linker between a substituted aryl system and the acridine nucleus was predicated by the electronic characteristics of the hydroxylamine and the potential additional hydrogen-bonding sites in the group.
Results and Discussion
The title compounds were prepared from the commercially available benzyl halides using a slight modification of the method by Bonaccorsi and Giorgi (Scheme 1). 10 Alkylation of N-hydroxyphthalimide (1) with an appropriately substituted benzyl chloride 2 produced the N-benzyloxyphthalimides 3 in good yields as white or off-white powders. Acidic hydrolysis of 3 in acetic acid followed by precipitation of product by bubbling anhydrous hydrogen chloride gas through the reaction mixture gave the expected N-benzylhydroxylamines as the hydrochloride salts 4. In many cases, the yield of the unmodified reaction gave only trace amounts of product. Improvement of the reaction yield in the decomposition of the phthalimide was accomplished by repeatedly recharging the reaction with additional hydrochloric acid. Yields for this step were variable and seemed to be loosely correlated to the electronic effect of the substituents on the benzyl group.
The desired title compounds, O-benzyl-N-(9-acridinyl)hydroxylamines were prepared by reacting the prepared hydroxylamines with 9-chloroacridine 11, 12 (5) as shown in Scheme 2. Initial attempts in this reaction resulted in relatively poor yields of 5, likely due to the limited availability of the free base of compounds 4. Use of potassium carbonate as a weak base in the reaction mixture dramatically improved the yield of the reaction. The desired compounds, 6, were isolated by extraction and purified by multiple chromatographic separations using radial chromatography. Spectroscopic analysis of the products in chloroform-d indicated severe line broadening for both proton and carbon resonances in the acridine ring system. This was particularly pronounced in the proton-NMR spectra. 13 Those same signals, however, sharpened in acetone-d6 hinting that restricted rotation about the N-O or C9-N bond might exist in 6. Moreover, it was observed that symmetrically related hydrogen atoms identified by 2-D NMR experiments on the acridine nucleus were identified as magnetically non-equivalent ( Figure 1 ). For example, separate resonances for the protons on C1 and C8 of the acridine in 6j occur at 8.06 ppm and 8.98 ppm, respectively. The acidic hydrogen was identified as the resonance at 9.33 ppm by shaking the acetone-d6 solution with a drop of D2O.
The existence of symmetrically related but non-magnetically equivalent hydrogens on the acridine nucleus posed a further issue about the structure of the isolated compound. It was theorized that the structure for the product 6g, for example, could be represented either as the hydroxylamine or as its tautomer, the oxime (Scheme 3). Free rotation about the C9-N bond in the hydroxylamine should allow the symmetrically related protons to exhibit a single resonance, assuming the rotation is fast on the NMR timescale. However, if the compound were to exist as the tautomeric oxime, then rotation about the C9-N bond wpi;d be very restricted and the apparent symmetrically related acridine hydrogen atoms would not be magnetically equivalent. While nitrogen inversion 14 would still allow for an exchange that would mimic rotation, sp 2 -hybridized inversion is significantly higher in energy that it would likely not occur to a large extent.
Measurement of the interaction of the title compounds 6 with double-stranded genomic calf thymus DNA was conducted by evaluation of the change in the thermal denaturation temperature of the DNA. 15 These measurements were taken with mixtures containing 1.5 x 10 -6 M DNA and 1.5 x 10 -6 M 6a-6l in a pH 6 phosphate buffer (0.01 M). A small amount of DMSO was added to maintain solubility (~5% DMSO). Use of the buffer solution at pH 6 was necessary given that the 9-hydroxylaminoacridines had an estimated pKa 6.3 and were therefore significantly less soluble at pH 7. 7 The thermal denaturation curves for many of the title compounds indicated a strong initial interaction with genomic DNA characterized by a significant decrease in the absorbance of the solution as the temperature increased to 50 °C. Then, as the temperature continued to increase beyond 50 °C, a bimodal denaturation curve was observed. The first inflection occurred at the melting point for the uncomplexed genomic calf thymus DNA and the second occurred at the proposed denaturation temperature of the DNA-6 intercalative complex. It is interesting to note that the thermal denaturation temperature changes range from 6.6 °C (weakly intercalating) to 20.2 °C (strongly intercalating). In addition, the majority of the compounds exhibited thermal denaturation temperature changes greater than 15 °C. This is suggestive of a mono-intercalating compound possessing a propensity to fully intercalate genomic DNA, rather than an associative binding to the grooves or phosphate backbone of genomic DNA. The denaturation temperatures for each of the compounds in the study are indicated in Table 1 . An MTT assay using the SNB-19 glioblastoma cell line was performed in triplicate for each of the title compounds. The reduction of MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2H tetrazolium bromide), a yellow tetrazole, to its insoluble formazan was observed and resulted in a color change that was easily monitored by a change in absorbance at 560 nm. 16 The reduction of the dye is dependent on NAD(P)H-dependent oxidoreductase enzymes that are found in large amounts within the cytosolic compartment of the cell. These enzymes are indicative of the number of viable cells within a sample as they are tied to cell proliferation. The reduction of the MTT dye, then, would be expected to increase with cellular metabolic activity due to elevated NAD(P)H flux. The results of the MTT assay versus the SNB-19 glioblastoma cell line on the title compounds (6) are collected in Table 1 .
Construction of a quantitative structure activity relationship (QSAR) using the calf-thymus DNA Tm values and the IC50 values from the MTT assay was attempted using various parameters. When each assay was correlated to the Hammett sigma values 17 of the benzyl substituents, very similar information was obtained. The addition of either an electron-withdrawing or electron-donating group caused an increase in biological activity from that of the unsubstituted compound. This indicates that any substitution on the benzyl ring resulted in an increase in activity. In fact, the specific nature of the substituents had little impact on the overall activity of the compound.
Yet, when the thermal denaturation values, Tm, were plotted against the MTT assay results, IC50, the correlation was observed as shown in Figure 3 . A slight preference for ortho substitution, with respect to the MTT assay, seems to be present, though significantly more data are needed to confirm this effect. In short, however, this evaluation indicates a correlation between the MTT assay results and the change in thermal denaturation temperature for calf-thymus DNA. The correlation reveals that substitution at the benzyl group of 6 favors biological interaction of the compound. The location of the substituent on the benzyl ring did not appear to influence the outcome of that biological interaction (as evidenced by the similar results seen for 6c-e and 6g-i, see Table 1 ). This is likely due to the fact that the benzyl ring is not conjugated to the acridine ring system (the intercalating portion of the molecule.) However, the fact that a difference was noted in the assays based on the presence of a substituent may hint that a conjugated version of the title compounds could possess significantly more pronounced effects. Such analyses on a fully conjugated system are currently being performed. 
Conclusions
A series of O-benzyl-N-(9'-acridinyl)hydroxylamines has been prepared and evaluated for their physical and biological properties as potential antitumor agents. Preparation of these compounds from the hydrochloride salts of the substituted hydroxylamines requires the addition of an excess of weak base in the phenol reaction solvent. Purification of the compounds using multiple separations on radial chromatography provided useful quantities of the pure compound 6 used for the evaluation of physical, spectroscopic, and biological properties. Thermal denaturation data for the series indicated a significantly strong interaction that will be further explored. The implication of the strong intercalative interaction with genomic DNA was confirmed by MTT assays. The title compounds are an interesting series of 9-substituted aminoacridines worthy of further study. In addition to their biological activity, these compounds possess restricted conformations in the solution phase. We are currently exploring the preparation, isolation, and evaluation of crystalline compounds for evaluation by diffraction. Obtaining a crystal structure of the compound would settle the question of the existence of the title compounds as hydroxylamines or oximes. Evaluation of these conformers could also provide additional insight into the observed effect of substitution on the benzyl group.
Experimental Section
General. Benzyl chloride, substituted benzyl chlorides, N-hydroxyphthalimide, 9-chloroacridine (5) and other reagents were obtained commercially from Sigma Aldrich, and were used after a determination of purity via 1 H NMR spectroscopy. Compounds 3 and 4 were prepared using the method of Bonaccorsi and Giorgi. 10 All solvents used were dried prior to use and their purity verified via spectroscopic methods. Hydrogen chloride gas was generated as needed through the addition of concentrated sulfuric acid to sodium chloride. Radial chromatography was performed using a Harrison Associates Chromatotron ® on 2 mm-thick silica gel plates containing fluorescent indicator that were pre-cleaned with MeOH and stored at elevated temperatures prior to use. NMR spectra were obtained on a Bruker Avance II (400 MHz for 1 H) multinuclear FT-NMR. The resonances for each atom in each compound were identified by 1D and 2D NMR techniques. Infrared spectra were collected using a Thermo Scientific iD5 ATR ZnSe cell. All UV-visible data were measured using an Agilent UV-visible diodearray spectrophotometer with a Peltier-temperature controller. MTT assay data were collected using published procedures. 16 N-(9'-acridinyl) hydroxylamines 6a-l. The appropriate salt, 4a-l, (7.02x10 -4 mol) was treated with 9-chloroacridine (5) (4.68x10 -4 mol). The reaction was carried out in molten phenol using 3.0 g of phenol per g of 9-chloroacridine (5). The reaction was heated between 80-100 °C for a period of 6-8 h, then cooled to rt and dissolved in CH2Cl2. The resulting orange or red organic solution was washed repeatedly with 0.25 M NaOH until greater than a 1:1 molar ratio of hydroxide to phenol was used. The organic phase was then washed with H2O (once) and brine (once). The organic layer was dried over anhydrous Na2SO4, gravity filtered, and concentrated to a final volume of approximately 1 mL. This sample was then transferred to the top of a 5-cm column of silica gel constructed from a 10-mL syringe barrel and eluted with EtOAc. The orange eluate was collected, concentrated to a final volume of 0.5-1.0 mL, and subjected to radial chromatography (2 mm plate, silica gel, CH2Cl2:Et2O 100:0 to 90:10 gradient elution). Compounds 6a-l were obtained in pure form by evaporation of the solvent from the bands that eluted. N-(9'-acridinyl)hydroxylamine (6a) . Yellow solid. Yield 64%, 1 H NMR (400 MHz, acetoned 6 ) δ, in ppm: 9.32 (s, 1H); 9.03 (d, J 8.4 Hz, 1H); 8.10 (d, J 8.0 Hz, 1H); 7.34 (m, 3H); 7.13 (m, 4H); 6.97 (m, 2H); 6.88 (m, 1H); 5.30 (s, 2H); 3.78 (s, 3H). 13 O-(2-Methylbenzyl)-N-(9'-acridinyl)hydroxylamine (6c) . Yellow-red solid. Yield 49%, 1 H NMR (400 MHz, acetone-d6) δ, in ppm: 9.31 (s, 1H); 8.95 (m, 1H); 8.09 (d, J 8.4 Hz, 1H); 7.47 (d, J 8.0 Hz, 1H); 7.34 (m, 2H); 7.23 (m, 3H); 7.12 (m, 2H); 6.98 (m, 2H); 5.33 (s, 2H); 2.45 (s, 3H). 13 O-(3-methylbenzyl)-N-(9'-acridinyl) O-(4-methylbenzyl)-N-(9'-acridinyl) O-benzyl-N-(9'-acridinyl) O-(3-chlorobenzyl)-N-(9'-acridinyl)hydroxylamine (6h) . Yellow solid. Yield 46%, 1 H NMR (400 MHz, acetone-d6) δ, in ppm: 9.37 (s, 1H); 9.00 (m, 1H); 8.08 (m, 1H); 7.40 (m, 6H); 7.10 (m, 2H); 6.98 (m, 2H); 5.32 (s, 2H). 13 O-(4-chlorobenzyl)-N-(9'-acridinyl)hydroxylamine (6i) . Yellow-orange solid. Yield 30%, 1 H NMR (400 MHz, acetone-d6) δ, in ppm: 9.34 (s, 1H); 8.98 (m, 1H); 8.06 (m, 1H); 7.54 (m, 2H); 7.40 (m, 4H); 7.14 (m, 1H); 7.08 (m, 1H); 6.97 (m, 2H); 5.30 (s, 2H). 13 
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